Print ISSN:-2249-8176

Online ISSN:-2348-7682

CODEN : PJMSD7

Current Issue

Year 2024

Volume: 14 , Issue: 2

  • Article highlights
  • Article tables
  • Article images

Article Access statistics

Viewed: 207

Emailed: 0

PDF Downloaded: 294


Kamat, Gatlewar, and Kini: Utility of haematological parameters and NESTROFT as screening tools for thalassemia trait- A study in a tertiary care hospital


Introduction

In India about 25 million people are identified as carrier and 6000 – 8000 children are born every year with thalassemia major1 . For early diagnosis and management of thalassemia syndromes, screening remains the backbone for diagnosing thalassemia trait and other haemoglobinopathies to identify the prevalence in developing country. 1

For screening purposes, a test which is inexpensive, requires a small amount of blood, does not require sophisticated equipment and can be applied on a large scale of population is usually preferred. These requirements are met by a modified osmotic fragility test “NESTROFT” ( Naked Eye Single Tube Red Cell Osmotic Fragility Test) a test first described by Kattamis et al. It is simple to perform, cost effective and has high sensitivity and specificity. 2

Combination of NESTROFT and application of various haematological formulas to various parameters helps to predict thalassemia trait, thus having an added value as screening tools.

The aim of this study was to apply NESTROFT to a suspicious group of thalassemia trait identified using various haematological parameters. Thereby correlating NESTROFT with these parameters and socio-demographic profile of patients to identify prevalence of thalassemia trait in outdoor patients of a tertiary care centre.

Materials and Methods

This study was prospective, observational and random selection study which was carried out in Pathology department at a tertiary care health centre, over a period of one and half years (June 2017- December 2018). A total of 5000 patients coming for treatment in various specialities with low haemoglobin formed the study group.

Inclusion criteria

All patients with low haemoglobin (as per WHO guidelines) irrespective of age, gender, caste, religion attending central pathology service laboratory (OPD). Exclusion criteria- Antenatal clinic (ANC) patients as samples of ANC patients are not processed in central pathology service laboratory of our hospital.

EDTA samples were collected and various hematological parameters such as RBC count, total haemoglobin concentration, haematocrit, RDW, MCV, MCH and MCHC using fully automated Cell counter (Model PCE-210 of ERMA INC Company) were estimated. Anaemic patients were identified based on cut off haemoglobin concentration to particular age and sex as per WHO guidelines. 3, 4

These patients were counselled, and Informed consent was taken for carrying out NESTROFT with recollection of EDTA sample. Mathematical formulas to predict type of anaemia was applied on significant haematological parameters. Hospital Ethics committee approval was attained prior to the study.

Different RBC indices and mathematical formulas used in the study were as follows 4

Table 1

Hematological index

Formula   

β thal trait

IDA

1

Mentzer index (MI)

MCV/RBC

<13

>13

2

England and Fraser (E and F)

MCV − (5 × Hb) − RBC − 3.4

<0

>0

3

Srivastava

MCH/RBC

<3.8

>3.8

4

Shine and Lal (S and L)

MCV × MCV × MCH/100

<1530

>1530

5

RDWI

MCV × RDW/RBC

<220

>220

6

Ricerca

RDW/RBC

<4.4

>4.4

7

Green and King (G and K)

MCV × MCV × RDW/Hb × 100

<65

>65

8

MDHL

(MCH/MCV) × RBC

>1.63

<1.63

9

MCHD

MCH/MCV

>0.3045

<0.3045

10

Ehsani

MCV − (10 × RBC)

<15

>15

11

RBC count

>5

<5

MDHL index: Mean Density of Hb/liter of blood;

MCHD index: Mean Cell Hb Density.

Socio - demographic profile and questionnaire was filled up. NESTROFT was done as per procedure and results of NESTROFT were signed off to the patients.

Principle of nestroft

Normally red cells put in saline solution begins to lyse at a saline concentration of 0.4-0.5% and lysis is complete at 0.32%. However, in thalassemia trait due to alteration in osmotic resistance of affected RBC’s (Value & surface area ratio changes) lysis which begins at a saline concentration between 0.4-0.35% may not be completed even at 0.1% solution. NESTROFT is at a saline concentration of 0.36%. 5

Procedure of test

2ml of 0.36% buffered saline was taken in sample test tube (T) and 2ml distilled water was taken in control test tube (C). 20 μl of blood was added to both tubes and are left undisturbed for half an hour at room temperature. Both tubes were shaken and held against a white paper with a black line. The line is clearly visible through the control tube(C). If the line was visible in (T), test is negative. If the line was not clearly visible in (T), test is positive5 as shown in Figure 1.

Figure 1
https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/09cae289-0d26-461c-a1cf-bf355694a31eimage1.png

All NESTROFT positive patients were counselled and referred to haematology OPD to undergo Hb electrophoresis by High Performance Liquid Chromatography (HPLC) (D10-BIORAD) method. Hb A2 level >3.5% was taken as the gold standard to diagnose beta-thalassemia trait.

The data was analysed using statistical software MiniTab 17.0 for calculating the p values. Comparison of mean between two groups was done using Unpaired 't' test, association between two non-parametric variables was done using Pearson Chi-square test and sensitivity, specificity, positive predictive value, negative predictive value and diagnostic value of each formula was calculated against the NESTROFT Results. Youden’s index = (Sensitivity + Specificity) - 100.

Results

Distribution of patients according to age, sex, religion and admission to various OPDs were evaluated. The evaluated patients were divided into two groups i.e Beta thalassaemia trait- NESTROFT Positive and non beta thalassaemia trait- NESTROFT Negative. Beta thalassaemia group includes positive NESTROFT and the standard reference values for various mathematical indices and peripheral smear showed microcytic hypochromic anemias. Non beta thalassaemia trait group includes negative NESTROFT and iron deficiency anaemias, anaemia of chronic diseases and sideroblastic anemias.

Sensitivity, specificity, positive predictive value and negative predictive value of NESTROFT and the various mathematical indices were evaluated and the significant difference between them was tabulated.

In 5000 cases analysed, age ranged from 1- 82 yrs. Majority of cases were seen in 21 – 60 yrs age group (75%) with a female preponderance (M:F- 1:1.8). According to religion, majority cases were hindus followed by muslims and boudh. Among hindus; Gujratis, sindhis, punjabis and other hindus were seen. According to speciality OPD’s; majority of patients were referred from Medicine OPD(40.2%) followed by Surgery OPD(23.8%) and Chemotherapy OPD(12%).

Out of 5000 cases, 152 were NESTROFT Positive. Among these 130 were further subjected to HPLC which was positive in 124 cases.

Majority of the patients in NESTROFT positive cases were in age group of 21-40 yrs with a female preponderance (M:f- 1:3.2). Maximum cases were gujratis followed by muslims and other hindus with maximum referral from Medicine OPD. On comparing various hematological parameters with NESTROFT test results as shown in Table 2, the mean RBC is found to be significantly higher in the NESTROFT Positive Cases, while Hemoglobin, HCT, MCV, MCH, and RDW were significantly lower in the NESTROFT Positive Cases. Further applying various mathematical formulae on hematological parameters, diagnostic accuracy for beta thalassemia trait was highest with Srivastava index (92.16%) and lowest with RICERCA index (25.24%) as shown in Table 3.

Table 2

2: Comparison of hematological parameters in relation to NESTROFT test results(n=5000)

Hematological Parameter

NESTROFT Positi[Mean ± SD] (n=152)

NESTROFT Negative [Mean ± SD] (n=4848)

T value

P value

RBC

5.36 ± 0.42

4.33 ± 0.95

13.330, df=4998

0.000*

Hemoglobin

9.74 ± 1.16

10.13 ± 1.29

-3.675, df=4998

0.000*

HCT

30.50 ± 4.01

32.12 ± 3.86

-5.086, df=4998

0.000*

MCV

63.07 ± 5.83

77.97 ± 10.99

-16.644, df=4998

0.000*

MCH

22.16 ± 4.25

24.71 ± 3.64

-8.474, df=4998

0.000*

MCHC

31.12 ± 1.79

31.79 ± 9.79

-0.861, df=4998

0.389, NS

RDW

14.71 ± 1.15

15.19 ± 2.11

-2.858, df=4998

0.004*

Table 3

Diagnostic accuracy of mathematical index in NESTROFT positive identified cases

Formula

Positive number of cases % age

Diagnostic accuracy

NESTROFT Test

152

3.0

100

Mentzer

664

13.3

89.44

England Fraser

406

8.1

91.72

Srivastava

352

7.0

92.16

Shine and Lal

2442

48.8

54.12

RDWI

1138

22.8

80.12

RICERCA

3886

77.7

25.24

Green and King

554

11.1

90.28

MDHL

816

16.3

85.12

MCHD

3580

71.6

29.84

Ehsani

680

13.6

89.12

RBC >5

1128

22.6

79.92

According to Sensitivity, Specificity, Youden’s index; good mathematical indices are in decreasing order as Mentzer index > Ehsani index > RDWI > RBC count > Green and King > MDHL > Shine and Lal > England Fraser > Srivastava > Ricerca > MCHD were ideal for screening tools to identify the beta -thalassemia trait cases a shown in Table 4. It also shows that while the association of NESTROFT was evaluated with Pearson Chi-square test (χ2), there was a statistically significant association seen between all mathematical indices and NESTROFT test except MCHD, showing that NESTROFT test is dependent on these indices.

In the NESTROFT positive group, peripheral smears of β-thalassaemia trait cases were evaluated and showed mild to moderate microcytosis, hypochromic red cells with mild anisocytosis. Target cell were seen in 70 (46%) cases.

Table 4

Shows Sensitivity, Specificity, Positive predictive value, Negative predictive value, Youden’s index

INDICES      

Sensitivity (%)

Specificity (%)

Positive Predictive Value (%)

Negative Predictive Value (%)

Youden’s Index (%)

Mentzer

94.74

89.27

21.69

99.82

84.01

Ehsani

94.74

88.9

21.18

99.81

83.64

RDWI

97.37

79.58

13.01

99.90

76.95

RBC count

90.79

79.58

12.23

99.64

70.37

Green and King

72.37

90.84

19.86

99.06

63.21

MDHL

73.68

85.48

13.73

99.04

58.85

Shine and Lal

98.68

52.72

6.14

99.92

51.4

England Fraser

47.37

93.11

17.13

98.26

40.48

Srivastava

36.84

93.89

15.19

97.93

30.73

Ricerca

98.68

22.94

3.86

99.82

21.62

MCHD

73.68

28.47

3.13

97.18

2.15

Discussion

Worldwide, underlying causes of anaemia are many, varied and largely preventable. These include nutritional deficiencies, infections and haemoglobin disorders. Worldwide frequency of beta thalassemia trait is about 3% whereas in India it ranges from 3 – 18 %. Certain communities such as Sindhis, Gujaratis, Kutchis, Lohanas, Punjabis, Mahars, Agris, Bhanushalis, Gaud, Saraswasts, Gowdas etc., have a higher frequency of beta thalassemia. 1

Prenatal diagnosis using genotyping techniques and various other confirmatory diagnostic tests are expensive to be made available in poorly resourced countries.

Hence various simpler, cost effective, easy to apply screening tools at outpatient clinics are beneficial to identify thalassaemia traits. These include NESTROFT and various mathematical formulae.

A total of 5000 outpatient clinic patients coming for treatment in various specialties with low haemoglobin formed the study group in which 152 were NESTROFT positive thereby suggestive of beta thalassaemia trait.

In the present study, NESTROFT positivity was seen in 152 cases with maximum number of patients in 21 – 40 years age group (80 patients; 52.6%) and a female preponderance (116; 76.3%). Maximum number of cases were seen in Gujratis (31.6%) followed by Muslims (27.6%) and other Hindus (19.7%). The biggest group was seen in patients referred from Medicine OPD (57.9%) followed by Surgery OPD (18.4%) and Paediatric OPD (18.4%). Similar observations were seen with Piplani S et al6 in which the maximum number of patients belonged to 21 – 30 years of age group (53 patients; 35.53%) and a female preponderance. Rao G B et al (2017) also showed male: female ratio of 1:3, with a female preponderance. 7

Out of the total 5000 cases studied 152 were NESTROFT Positive. Among these 130 subjected to HPLC further confirmed positivity in 124 cases. The diagnostic accuracy of NESTROFT Test was found to be 100.0%. Regarding the usefulness of the NESTROFT as a screening test for the detection of beta thalassaemia trait, present study corroborated well with other studies as shown below Table 5.

Table 5

Authors

Year

Sensitivity (%)

Specificity (%)

Positive Predictive Value (%)

Negative Predictive Value (%)

Sirichotivakul et al 8

2004

97.6

72.9

33.6

99.5

Chakraborty et al 9

2012

94.12

95.23

41.02

99.78

Piplani s et al 10

2013

100

85.47

66

100

Present study

2019

100

100

100

100

Hence, the NESTROFT Test was used as an alternative test to HPLC in the present study.

Further on correlation of the RBC indices and other mathematical indices with other similar studies, the mean haemoglobin values of our study group was 9.74 ± 1.16 g/dl which was lower than that of observation made by Chakraborty et al, 11 Vehapoglu A et al 9 and Piplani S et al 10 who reported haemoglobin of 10.09±0.65 g/dl, 10.39±0.69 g/dl and 10.7±0.8 g/dl respectively.

The mean red blood cell count values of our study was 5.26 ± 0.42, 106/cmm which was almost similar to that of the observation of ICMR Study. 12 Higher mean RBC count has been reported by Vehapoglu A et al 10 (5.56±0.4) and Piplani S et al 10 (5.79±0.76). Lower mean RBC count has been reported by Chakraborty et al11 (10.09±0.65).

The mean MCV of our study group was 63.07±5.83 fl which was almost similar to that of the observations made by Chakraborty et al 11 and Piplani S et al. 10 Higher mean MCV has been reported by Madan et al 8 (64.7 ± 4.8).

On comparison of various mathematical indices in beta thalassemia trait positive cases in present study with some earlier studies showed that in the present study, Mentzer Index exhibited a reasonably high sensitivity, specificity, good Youden’s index and diagnostic accuracy of 94.74%, 89.27%, 84% and 89.4% respectively. Similar observations were proposed by Ehsani et al 13 in which sensitivity, specificity, Youden’s index and diagnostic accuracy were as 94.6%, 95.5%, 94.71% and 90.1% respectively. Almost similar results have been documented by Piplani S et al,10 Rahim et al 14 and Vehapoglu A et al 9 who recorded sensitivity and specificity of 94.4% and 86.9% respectively.

In the present study, Ehsani Index also exhibited high sensitivity, specificity, good Youden’s index and diagnostic accuracy of 94.74%, 88.94%, 83.64% and 89.12% respectively. Similar observations were proposed by Ehsani et al 13 in which sensitivity, specificity, Youden’s index and diagnostic accuracy of 90%, 95.5%, 85.5% and 92.9% respectively which also corroborated well with Vehapoglu A et al 5 and Piplani s et al.2

In the present study, RDWI also showed high sensitivity, specificity, good Youden’s index and diagnostic accuracy of 97.37%, 79.58%, 76.95% and 80.12% respectively which are comparable with the findings of Rahim et al,14 Niazi M et al,15 Adlekha S et al1 and Tong L et al.16

In the present study, RBC count >5 showed sensitivity, specificity, Youden’s index and diagnostic accuracy of 90.79%, 79.58%, 76.37% and 79.92% respectively which are comparable with the findings of Rahim et al14 who found these to be 94%, 84%, 72% and 90% respectively. Almost similar results have been documented by Vehapoglu A et al9 and Jameel T at al.17

Alfadhli S M et al18 and Ferrara M et al19 documented not only high Youden’s index but also high specificity for England and Fraser index. But in the present study though the specificity was 93.11%, this index showed a Youden’s index of just 40.48%. In the present study, the Srivastava index showed a sensitivity, specificity and low Youden’s index of 36.84%, 93.89% and 30.73% respectively. Niazi M et al15 also found a low Youden’s index of 27%.

England and Fraser (1979) after evaluation of 1500 peripheral smears of beta thalassaemia traits concluded that microcytic hypochromic red cells and significant target cells are an important finding.20 The present study also showed mild to moderate microcytic hypochromic red cells, with mild anisocytosis in majority of beta thalassemia trait cases and 46% cases showed presence of target cells.

The best laboratory index of a screening test for beta thalassaemia trait should have a very high sensitivity as well as a reasonably high specificity so that the false positivity can be decreased.

In present study, NESTROFT positive results were correlated well with mathematical indices and we found Mentzer index > Ehsani index > RDWI > RBC count > Green and King were ideal for screening cases of beta thalassemia trait as they showed statistically significant results. Other indices like MDHL, Shine and Lal, England Fraser, Srivastava, Ricerca though statistically significant were not of much use in our study. MCHD also did not show statistically significant results. We observed a low positive predictive value in our study which may be due to non-targeted population of study group.

Haematological parameters in the present study group were on lower side as the cases were included from lower socioeconomic status, coexistence of iron deficiency anemia and referrals from various speciality OPD’s like chemotherapy and anti-retroviral therapy OPD.

Though all NESTROFT positive patients were counselled and referred to haematology OPD to undergo HPLC, only 130 cases followed up. Remaining 22 cases were lost to follow up due to unawareness and not understanding significance about disease, illiteracy and lower socioeconomic status.

To conclude, in the present study, various mathematical indices were used but none of those indices shows sensitivity and specificity of 100%, while NESTROFT shows sensitivity and specificity of 100%. Hence, both haematological parameters and NESTROFT have to be used in conjunction as primary screening tools for thalassemia trait in general population. Based on reliability, cost effectiveness and non-requirement of hi-tech equipments, it makes it an ideal contender to be adopted in rural settings of developing countries, for early diagnosis and thereby decreasing the morbidity associated with thalassemia.

Conflicts of Interest

No potential conflict of interest relevant to this article was reported.

Source of Funding

None.

References

1 

S Adlekha T Chadha R M Jaiswal A Singla Screening of b-thalassaemia trait by means of red cell indices and derived formulaeMed J DY Patil Univ20136171410.4103/0975-2870.108649

2 

C Kattamis G Effremov S Pootrakul Effectiveness of one tube osmotic fragility screening in detecting beta Thalassemia traitJ Med Genet198118426670

3 

WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva, World Health Organization, 2011 (WHO/NMH/NHD/MNM/11.1)

4 

J Dacie S Lewis Haematology 4. Ed. 1st ed. London: J. A. Churchill 1968

5 

C Prasad S B Singh GK Gupta S Praksh T Mahato S Chandra Eye Single Tube Red Cell Osmotic Fragility Test Screening For Detection Of B-Thalassemia Trait - An Evaluation Against HPLC Method At Rajendra Institute Of Medical Sciences, Ranchi (A Tribal Zone )RJPBCS201454138896

6 

S Piplani R Manan M Lalit M Manjari T Bhasin J Bawa Cost Effective Screening Test for Beta Thalassemia Trait in North Indian Punjabi PopulationJ Clin Diag Res2013712268778410.7860/JCDR/2013/6834.3759

7 

G Rao Correlation of Hematological Parameters and NESTROFT in A Routine Hematology Laboratory - A Prospective StudyIOSR J Dent Med Sci (IOSR-JDMS)201716491210.9790/0853-1604020912

8 

N Madan S Meera S Satendra U Rusia K Kela Red cell indices and discriminant functions in the detection of beta thalassemia trait in a population with high prevalence of iron deficiency anaemiaInd J Pathol Microbiol19994215561

9 

A Vehapoglu G Ozgurhan A D Demir S Uzuner M A Nursoy S Turkmen Hematological indices for for differential diagnosis of Beta thalassemia trait and iron deficiency anemiaAnemia201410.1155/2014/576738

10 

S Piplani Is NESTROFT better than the hematological indices for screening of beta-thalassemia trait: an answer in rural scenarioIndian J Pathol Oncol2017416370

11 

I Chakrabarti SK Sinha N Ghosh BK Goswami Beta thalassemia carrier detection by NESTROFT: an answer in rural scenarioIranian J Pathol2012711926

12 

Collaborative study on Thalassemia. An ICMR task force study New Delhi, Indian Council of Medical Research1993149

13 

M A Ehsani E Shahgholi M Rahiminejad F Seighali A Rashidi A new index for discrimination between iron deficiency anemia and beta-thalassemia minor: Results in 284 patientsPak J Biol Sci2009125473810.3923/pjbs.2009.473.475

14 

F Rahim B Keikhaei Better differential diagnosis of iron deficiency anemia from beta-thalassemia traitTurk J Haematol200926313845

15 

M Niazi M Tahir A Hameed Usefulness of red cell indices in differentiating microcytic hypochromic anemias Gomal J Med Sci20108

16 

L Tong A new red cell index and portable RBC analyzer for screening of iron deficiency and Thalassemia minor in a Chinese populationSci Rep201771051010.1038/s41598-017-11144-w

17 

T Jameel M Baig I Ahmed MB Hussain MD Alkhamaly Differentiation of beta thalassemia trait from iron deficiency anemia by hematological indicesPak J Med Sci20173336659

18 

SM Alfadhli AM Al-Awadhi D Alkhaldi Validity assessment of nine discriminant functions used for the differentiation between Iron deficiency anemia and thalassemia minorJ Trop Pediatr200753293100

19 

M Ferrara L Capozzi R Russo Reliability of red blood cell indices and formulas to discriminate between 𝛽 thalassemia trait and iron deficiency in childrenHematology20101521125

20 

J M England P Fraser Discrimination between Iron deficiency and heterozygous thalassaemia syndromes in the differential diagnosis of microcytosisLancet197918108145810.1016/s0140-6736(79)90532-4



jats-html.xsl

© 2022 Published by Innovative Publication Creative Commons Attribution 4.0 International License (creativecommons.org)